CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Children’s Hospital Association Opposes Actions That Limit Access to Care for Children
Milestones that Matter: Driving Progress for Children's Health
Children's Hospital Association Comments on Changes to Childhood Vaccine Schedule
Children’s Hospital Association Opposes Actions That Limit Access to Care for Children
New proposed federal actions could jeopardize access to quality care for 30 million children nationwide.
Dec. 18, 2025
Milestones that Matter: Driving Progress for Children's Health
From advocacy to innovation, the Children’s Hospital Association led with purpose in 2025.
Dec. 15, 2025
Children's Hospital Association Comments on Changes to Childhood Vaccine Schedule
In response to ACIPs changes to guidance on the Hepatitis B vaccine for children.
Dec. 05, 2025
